Metagenomi Inc (MGX)
6.55
-0.01
(-0.15%)
USD |
NASDAQ |
Jun 05, 16:00
Metagenomi Shareholders Equity (Quarterly): 275.63M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 275.63M |
December 31, 2023 | -135.58M |
September 30, 2023 | -119.02M |
Date | Value |
---|---|
June 30, 2023 | -102.54M |
June 30, 2023 | -102.54M |
December 31, 2022 | -74.43M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-135.58M
Minimum
Dec 2023
275.63M
Maximum
Mar 2024
-43.08M
Average
-102.54M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Moderna Inc | 12.82B |
Ionis Pharmaceuticals Inc | 296.52M |
Beam Therapeutics Inc | 913.49M |
Verve Therapeutics Inc | 583.07M |
Prime Medicine Inc | 243.77M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 415.40M |
Total Liabilities (Quarterly) | 139.77M |
Current Ratio | 4.747 |